These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 5031449)

  • 1. [Studies on the spasmolytic efficacy of prifinium bromide in gastrointestinal pathology].
    Garcia Hidalgo E; Fernández Navarro MD; Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1972 May; 37(3):397-406. PubMed ID: 5031449
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antispasmodic action of prifinium bromide].
    Herraíz Soler M; Berenguer Lapuerta J; Baquena Candela J
    Rev Clin Esp; 1972 Jan; 124(2):179-84. PubMed ID: 5015513
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical use of prifinium bromide: a new spasmolytic agent].
    Marini U; Spotti D; Visconti P
    Clin Ter; 1978 Nov; 87(4):367-74. PubMed ID: 36254
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences with a new selective antispastic derivative of anisotropine].
    Vignola D; Galvani A
    Clin Ter; 1968 Oct; 47(2):175-85. PubMed ID: 5755355
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trial of a new analgesic and antispastic drug combination].
    Mariani L; Pinto E
    Clin Ter; 1975 Feb; 72(3):255-73. PubMed ID: 48445
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacology of an anticholinergic Sch-3444 or 4-(1-methyl-piperidyl)benzilate methylbromide. Experimental and clinical study].
    Maggi ND; Camponovo LE; Marchese MJ; Bertorello MC
    Prensa Med Argent; 1967 Apr; 54(8):375-9. PubMed ID: 5628940
    [No Abstract]   [Full Text] [Related]  

  • 7. [Controlled clinical study of the oral use of Ketoscilium in dyskinetic-spastic disorders of the digestive tract].
    Maduli S; Frigerio G
    Minerva Gastroenterol; 1970; 16(2):94-8. PubMed ID: 5477402
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical studies of GE 1783].
    Greif S; Stampfer E
    Wien Med Wochenschr; 1972 Sep; 122(40):568-70. PubMed ID: 4562563
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical use of prifinium bromide in the treatment of pain caused by hypertonia of smooth muscle].
    Scalco GB; Guerrera C; Liboni A; Malin L
    G Clin Med; 1978; 59(9-10):430-42. PubMed ID: 33098
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trial and evaluation of a new hepatoprotector, choleretic and antispasmodic preparation].
    Fernández Navarro MD; García Pérez M; Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1972 Oct; 38(4):503-10. PubMed ID: 4629092
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experimentation with pentanobornamide, a new synthetic spasmolytic].
    Miracco A; Peluso C
    Clin Ter; 1970 Mar; 52(6):557-63. PubMed ID: 4916457
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic experiences with a central sedative and peripheral analgesic-spasmolytic medication combination in gastrointestinal diseases].
    Lampe W
    Med Welt; 1968 Jun; 23():1427-30. PubMed ID: 5718202
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical trials of a combination of an original gastric demulcent and a synthetic anticholinergic agent].
    Evreux M; Jenoudet L
    Lyon Med; 1972 Jun; 227(11):1181-4. PubMed ID: 4564809
    [No Abstract]   [Full Text] [Related]  

  • 14. [Indications of parapenzolate in digestive pathology].
    Boisson J
    Therapeutique; 1970 May; 46(5):561-5. PubMed ID: 5430230
    [No Abstract]   [Full Text] [Related]  

  • 15. [Controlled evaluation of a new synthetic spasmolytic (DA 3177) in/pathology of the digestive system].
    Battocchio F; Negri L; Tacchettti G
    Clin Ter; 1979 Jun; 89(6):601-10. PubMed ID: 397029
    [No Abstract]   [Full Text] [Related]  

  • 16. [Benzilonium bromide in hyperhydrosis].
    Stromme A
    Tidsskr Nor Laegeforen; 1969 Dec; 89(24):1898-9. PubMed ID: 5377175
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study of modirit (apropos of 30 cases)].
    Warembourg H; Vasseur P
    Lille Med; 1971 Jan; 16():Suppl 1:238-40. PubMed ID: 4145785
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical observations on the effect of a synthetic product with spasmolytic action, on abdominal pain manifestations].
    Ciravegna G; Michetti P; De Conca V
    Clin Ter; 1971 May; 57(3):227-36. PubMed ID: 5110943
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinico-instrumental study of the therapeutic action of a new parasymaptholytic].
    Barbara L; Corinaldesi R; Macaluso G; Luchetta L; Ricci P; Casadio R; Miglioli M
    Clin Ter; 1976 Dec; 79(6):523-47. PubMed ID: 12909
    [No Abstract]   [Full Text] [Related]  

  • 20. Double-blind study of a psychotropic-anticholinergic drug in gastric disorders.
    Cromwell HA
    Med Times; 1968 Sep; 96(9):933-8. PubMed ID: 4876840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.